Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Randomized, Controlled Evaluation of the Safety & Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

NCT01459679 is registered in ClinicalTrials.gov with American-European Congress of Ophthalmic Surgery as lead sponsor.

NCT NCT01459679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01459679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Randomized, Controlled Evaluation of the Safety & Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery
Lead sponsor
American-European Congress of Ophthalmic Surgery
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2012
Completion date
August 31, 2016
Enrollment
1,721 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

corneal ectasia, keratoconus